Cargando…
Idiopathic pulmonary fibrosis in Brazil: challenges for epidemiological characterization and management
Autor principal: | Baldi, Bruno Guedes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Pneumologia e Tisiologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792034/ https://www.ncbi.nlm.nih.gov/pubmed/29340483 http://dx.doi.org/10.1590/S1806-37562017000060003 |
Ejemplares similares
-
Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in Brazil
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2019) -
Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification
por: Baldi, Bruno Guedes, et al.
Publicado: (2021) -
Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?
por: Bridi, Guilherme das Posses, et al.
Publicado: (2023) -
Update on diagnosis and treatment of idiopathic pulmonary fibrosis
por: Baddini-Martinez, José, et al.
Publicado: (2015) -
Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics
por: Hochhegger, Bruno, et al.
Publicado: (2019)